news

News

Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.

Alimentiv Launch Announced

Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO).

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study

ST. PAUL, Minn., June 25, 2020 (GLOBE NEWSWIRE) — Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC).

Gutsy Walk – Alimentiv Corporate Team

Our corporate team "IBD Eliminators" are featured as the Corporate Team for Gutsy Walk! Including dedicated employees of Alimentiv Clinical Trials and supportive friends and family, our team has participated since 2017.

Facilitating Drug Development in Under-served Patient Populations

Development of a Radiological Index for Peri-anal Crohn’s Disease

Optimal Biopsy Location for Biomarker Analyses

The appropriate location for biopsy sampling is a common question in gastrointestinal diseases such as Crohn’s disease (CD) and ulcerative colitis (UC). Standardization of biopsy procurement is essential during drug development to define response to therapy.